Beldarrain, G.; Hilario, E.; Lara-Celador, I.; Chillida, M.; Catalan, A.; Álvarez-Diaz, A.Á.; Alonso-Alconada, D.
The Long-Term Neuroprotective Effect of the Endocannabinoid 2-AG and Modulation of the SGZ’s Neurogenic Response after Neonatal Hypoxia-Ischemia. Pharmaceutics 2023, 15, 1667.
https://doi.org/10.3390/pharmaceutics15061667
AMA Style
Beldarrain G, Hilario E, Lara-Celador I, Chillida M, Catalan A, Álvarez-Diaz AÁ, Alonso-Alconada D.
The Long-Term Neuroprotective Effect of the Endocannabinoid 2-AG and Modulation of the SGZ’s Neurogenic Response after Neonatal Hypoxia-Ischemia. Pharmaceutics. 2023; 15(6):1667.
https://doi.org/10.3390/pharmaceutics15061667
Chicago/Turabian Style
Beldarrain, Gorane, Enrique Hilario, Idoia Lara-Celador, Marc Chillida, Ana Catalan, Antonia Ángeles Álvarez-Diaz, and Daniel Alonso-Alconada.
2023. "The Long-Term Neuroprotective Effect of the Endocannabinoid 2-AG and Modulation of the SGZ’s Neurogenic Response after Neonatal Hypoxia-Ischemia" Pharmaceutics 15, no. 6: 1667.
https://doi.org/10.3390/pharmaceutics15061667
APA Style
Beldarrain, G., Hilario, E., Lara-Celador, I., Chillida, M., Catalan, A., Álvarez-Diaz, A. Á., & Alonso-Alconada, D.
(2023). The Long-Term Neuroprotective Effect of the Endocannabinoid 2-AG and Modulation of the SGZ’s Neurogenic Response after Neonatal Hypoxia-Ischemia. Pharmaceutics, 15(6), 1667.
https://doi.org/10.3390/pharmaceutics15061667
